🇺🇸 FDA
Patent

US 9139634

Interferon-antibody fusion proteins demonstrating potent apoptotic and anti-tumor activities

granted A61KA61K2039/505A61K38/00

Quick answer

US patent 9139634 (Interferon-antibody fusion proteins demonstrating potent apoptotic and anti-tumor activities) held by The Regents of the University of California expires Mon Sep 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Sep 22 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K2039/505, A61K38/00, A61K38/212, A61K38/215